Stocks-PTGX-Protagonist Therapeutics Inc

PTGX Protagonist Therapeutics Inc

14.33 -0.13 (-0.90%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest
0% Past Week
Market Cap
705.01M
Day’s Range
14.16
-
14.55
52W Range
6.84
-
30.33
Volume (3M)
905.64K
Price-Earnings Ratio
-
Revenue
35.2M
Top Discussions

About Protagonist Therapeutics Inc

Protagonist Therapeutics is a healthcare company based in Newark, California, US and established in 1996. Operating locally, the company aims to meet as-yet-unmet medical requirements through the use of peptide drugs. It is traded on the NASDAQ GM under the stock ticker PTGX. PTGX stock is available on eToro. Learn more now!
118
Employees
Newark, California, US
HQ
2006
Founded
Dinesh V. Patel, PhD
CEO
Show More

Upcoming Earnings

27
FEB
REPORTS
Protagonist Therapeutics Inc Q4 2022 earnings report is expected to be released after market open

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
53
Medium
Industry 
Avg. 45 
32
Environment
46
Social
68
Governance

People Also Bought